NCT00652418 - Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions

Magnetic Resonance AngiographyPeripheral Vascular DiseasesPeripheral Arterial Diseases

Interventions

DRUG

Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)

Magnevist at a dose of 0.1 mmol/kg

DRUG

Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)

Magnevist at a dose of 0.2 mmol/kg

Trial Locations (3)

Hirosaki-shi

Funai-gun

Hamamatsu